Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I receive many emails for GBEN proven winner: potenially soar to $.26 cents
volume is decent for the run
see $0.4 soon
we will see something out soon!
Good point to enter!
CBIS history will repeat itself!
From 5 to 25!
GO CBIS!
up again?
Any PR out?
what is the target: $0.4?
CBIS nice consolidation at $0.05!
We will see CBIS run soon!
GO CBIS!
Become a penny stock this week?
20 mil in half an hour, wow!
Green, GO CBIS!
Green, Green, Green, Go CBIS!!!
Very Good!
We will see how CBIS products work on Kaposi's sarcoma in the next future!
Go CBIS!
knocking the door!
You will see it!
different extrac-technique may create different effect. Cbis will do it
but cbis products work
maybe the div will be issued in the next future.
there is a promising future for CBIS
nobody will let CBIS bankrupt since there are golden sources of 100 mil both class a and b shares, needless to say its FDA application.
10 mil XCHC shares or more?
So far, there is not any information about Phytiva released in 8Ks from both CBIS and XCHC. XCHC appointed some persons, but some one resigned (fired?)from CBIS.
From the 8K and PRs from XCHC, it looks like CBIS was betrayed. Maybe, that is reason for a later 8K without PR. CBIS still holds Phytiva.
Why did not XCHC 8K mention Phytiva, but in PRs?
Why not? You keeping dumping!
If there is a link, CBIS will be over $1. According to current situation and information, something is brewing, imo.
The FDA application of CBIS is approaching.
Go CBIS!
If CBIS submits the FDA application, the value of cosmetic products will completely be ignored. Maybe, this is the reason for the transfer.
CBIS keeps a long and great silence at this issue. Is it possible for CBIS: transfer something valuable into another place before the FDA application?
If CBIS still owns Phytiva, XCHC released a series of false PRs, based on its 8K.
If all are as the 8K, it looks like the conflict is settled down. Phytiva is still in the hand of CBIS. Everyone knows its value.
I am confused on both positive and negative sides: who make a real analysis based on real situation and source?
There are 100,000,000 of Common Class A and B available in CBIS, especially Common Class A. If CBIS is a shell company, it is unreasonable to give up those shares. Also CBIS will at least submit an attempt for FDA application if the management team is commonly intelligent, which is the big pump.
It is too early to say that. Maybe, CBIS has a special process for the cannabis oil, such as the extract process of arteannuin.
Do not worry: if someone is not satisfied with this deal with XCHC, they will create a wife for this transaction.
So Trimcare withdrew its clinic, vice versa for CBIS.
Did CBIS get Trimcare? Is withdraw an appropriate word?
What will happen if CBIS withdraws Phytiva?
More and more possible, XCHC is another Trimcare, imo. 0.25 is not impossible.
Really?
There is not 8K at all before the conflict is settled down. Too greedy, not reasonable.